Tennstedt Sharon
Urology. 2005 Dec;66(6):1213-7. doi: 10.1016/j.urology.2005.06.089.
To describe the methods and rationale for the first randomized controlled trial conducted by the Urinary Incontinence Treatment Network.
The primary objective of this clinical trial is to compare two commonly performed surgical procedures for stress urinary incontinence-the Burch colposuspension and the autologous rectus fascial sling-for overall treatment success for urinary incontinence and stress-type symptoms of incontinence at 24 months after surgery. Secondary aims include a comparison of complications, quality of life, sexual function, patient satisfaction, costs, and the need for additional treatments or surgery; and an evaluation of the prognostic value of preoperative urodynamic studies. The Stress Incontinence Surgical Treatment Efficacy Trial is being conducted on 655 women with predominant stress urinary incontinence, as determined by history and physical examination, urinary stress test with witnessed leakage, and voiding diary. Administration of all questionnaires and performance of examinations, tests, and both surgical procedures are standardized within and across the clinical centers. Assessments occur preoperatively and at 6 weeks and 3, 6, 12, 18, and 24 months postoperatively. A sample of 655 women ensures 80% power to detect a 12% difference (60% versus 72%) at the 5% significance level. The intent-to-treat analysis will use Fisher's exact test and time-to-failure analyses.
Enrollment was completed in June 2004 with 24 months of follow-up to end in June 2006.
This is the first large, multicenter randomized clinical trial comparing these two standard-of-care procedures for stress incontinence.
描述尿失禁治疗网络开展的第一项随机对照试验的方法和基本原理。
本临床试验的主要目的是比较两种常用于治疗压力性尿失禁的外科手术——Burch阴道悬吊术和自体腹直肌筋膜吊带术——在术后24个月时尿失禁总体治疗成功率以及压力性尿失禁症状的治疗效果。次要目的包括比较并发症、生活质量、性功能、患者满意度、成本以及额外治疗或手术的需求;并评估术前尿动力学研究的预后价值。压力性尿失禁手术治疗疗效试验正在655名以压力性尿失禁为主的女性中进行,这些女性通过病史和体格检查、有漏尿见证的尿动力学压力试验以及排尿日记确定。所有问卷的发放以及检查、测试和两种外科手术的实施在各临床中心内部和之间都是标准化的。评估在术前以及术后6周、3个月、6个月、12个月、18个月和24个月进行。655名女性的样本确保在5%的显著性水平上有80%的把握度检测出12%的差异(60%对72%)。意向性分析将采用Fisher精确检验和失效时间分析。
入组于2004年6月完成,24个月的随访将于2006年6月结束。
这是第一项比较这两种压力性尿失禁标准治疗方法的大型多中心随机临床试验。